Agomab Therapeutics
Series D+Agomab Therapeutics raised €83M in a Series D+ round in Oct 2024. The company is based in Ghent, Belgium. Investors in the round: Asabys Partners, Invus, Sanofi Ventures. Data as of Nov 2026.
Amount raised
€83M
€83,140,878
Native amount
90,000,000 USD
Stage
Series D+
series d
Investors
3
Provenance & confidence
High confidenceAmount
90,000,000 USD
ECB-at-date → €83M · rate 1.0825 on 2024-10-25
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Oct 2024
Round type
series d
Amount (EUR)
€83M